Filing Details
- Accession Number:
- 0001209191-23-045494
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-11 20:00:09
- Reporting Period:
- 2023-08-01
- Accepted Time:
- 2023-08-11 20:00:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1718108 | Surface Oncology Inc. | SURF | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1733077 | W. Robert Ross | C/O Surface Oncology, Inc. 50 Hampshire Street, 8Th Floor Cambridge MA 02139 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-08-01 | 16,713 | $0.94 | 83,193 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Amount reported represents the number of shares sold by the reporting person to cover the tax withholding obligations in connection with the vesting of restricted stock units.